VitaFLUX for Women: What the Label Says

VitaFLUX for Women is an amino-acid supplement made by Absorption Pharmaceuticals, the company behind Promescent. Its label lists 2,000 mg L-arginine, 1,000 mg L-citrulline and 1,000 mg L-carnitine per 6-capsule daily serving, plus magnesium and zinc. The maker says it supports blood flow, natural lubrication and stronger orgasms. Those are the maker’s claims: the product page cites no clinical study of VitaFLUX for Women, and we found none. Here is what the label says, how it is taken, and the safety points that matter most.

What the label says

Other ingredients: hydroxypropyl methylcellulose (the capsule), magnesium stearate, maltodextrin and silicon dioxide. The container holds 30 servings.

How it is taken

The manufacturer’s directions are 3 capsules in the morning and 3 in the evening, with or without food. If you take other supplements, add up the magnesium and zinc from all of them.

Claims vs evidence

The maker’s idea is that arginine and citrulline help the body make nitric oxide, which relaxes blood vessels. That is how these amino acids work in the body, but it doesn’t show that this product improves arousal, lubrication or orgasm in women. The main arginine evidence we cite elsewhere, a 2019 meta-analysis of 10 small trials, was in men with erection problems and used different doses and products. It can’t be taken as proof for VitaFLUX for Women.

Safety

Mayo Clinic lists these points for L-arginine, the largest ingredient:

• Possible side effects: nausea, stomach pain, diarrhoea, bloating, headache, allergic reactions and worsening asthma.
• Blood pressure: combined with blood-pressure medicines or nitrates, blood pressure may drop too low.
• Bleeding: higher bleeding risk with blood thinners.
• Potassium: a high-potassium risk with potassium-sparing diuretics.
• Heart: not recommended after a recent heart attack.

The label we read doesn’t include specific warnings about pregnancy, breastfeeding or medicines. If any of these apply to you, or you take regular medicine, ask a doctor or pharmacist before starting.

If low desire is the real issue

The NHS lists many possible causes of low sex drive in women: relationship problems, stress, depression and anxiety, vaginal dryness, pregnancy and the months after birth, menopause, some medicines (including certain antidepressants and blood-pressure drugs), hormonal contraception, alcohol and long-term conditions such as diabetes or thyroid problems. Treatment depends on the cause, so a GP visit is a better first step than any supplement if it is worrying you.

The takeaway

VitaFLUX for Women is an amino-acid supplement whose benefits are the maker’s claims; there is no published study of the product. Check the magnesium and zinc in everything you take, talk to a doctor first if you take blood-pressure medicines, nitrates or blood thinners, and see a GP if low desire is worrying you.

We buy our products directly from the brands’ official websites or arrange supply directly with the companies; we are not an authorised distributor. See the VitaFLUX for Women product page for the current price and stock.

Bangladesh: order on the website with cash on delivery; delivery terms are on our Delivery & Return page. Qatar: Available in Qatar. To order, contact WhatsApp WhatsApp Qatar. In-stock products can be supplied; other products are available for pre-order, subject to confirmation.

Sources

• Promescent (Absorption Pharmaceuticals): VitaFLUX for Women, supplement facts and directions
• Rhim et al. (2019), Journal of Sexual Medicine: Arginine supplements and erectile dysfunction (meta-analysis)
• Mayo Clinic: L-arginine
• NIH Office of Dietary Supplements: Magnesium
• NIH Office of Dietary Supplements: Zinc
• NHS: Loss of libido

About this guide: researched and drafted with AI assistance (Claude) from the sources listed above, and published by Amzad Hosen, owner of Vita Health Care. We have not tested this product, and the guide has not been medically reviewed. This is general information, not medical advice. Last reviewed: 1 October 2026.